| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Tetrault Lynn A. is a Director at NEO, with reported holdings spanning 3 companies. Recent filings cover 3 purchases and 14 sales. Those positions are worth an estimated $956K at current prices.
Our model assigns Tetrault Lynn A. a below-average insider score of 37/100, based on 6 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -57.8%.
Tetrault Lynn A.'s largest disclosed position is in NEO as Director, worth about $956K. The recent filings there lean toward selling, a net 14,726 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 37,000 | $100.32 | $3,711,895.50 | -84.1% | -2.5% | - | |
| Jun 15, 2026 | NEO Neogenomics, Inc. | Director | Sell10b5-1 | 5,307 | $11.10 | $58,907.70 | -5.8% | +66.0% | - | |
| Jun 9, 2026 | NEO Neogenomics, Inc. | Director | Sell10b5-1 | 5,307 | $11.29 | $59,916.03 | -5.5% | +53.5% | - | |
| May 9, 2025 | NEO Neogenomics Inc | Director | Buy | 7,000 | $8.14 | $56,974.40 | New | -28.4% | +11.3% | |
| Sep 10, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 20,700 | $49.71 | $1,028,991.13 | -87.3% | +16.9% | +104.3% | |
| Aug 26, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 4,300 | $50.01 | $215,028.81 | -58.9% | +19.8% | +102.4% | |
| Aug 12, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 10,000 | $44.65 | $446,461.81 | -76.9% | +47.4% | +116.9% | |
| Mar 4, 2024 | NEO Neogenomics Inc | Director | Sell10b5-1 | 6,112 | $15.97 | $97,578.69 | -10.9% | -15.9% | -41.9% | |
| Nov 19, 2018 | NEO Neogenomics Inc | Director | Sell | 13,000 | $16.00 | $207,940.00 | -25.4% | - | - | |
| Nov 14, 2018 | NEO Neogenomics Inc | Director | Sale+OE | 5,000 | $16.16 | $80,800.00 | -8.9% | - | - |